Citadel Advisors’s Braskem BAK Stock Holding History

Citadel Advisors’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,200	Closed	-$296K	–	8803
2018 Q1	$296K	Buy	+10,200	New	+$297K	﹤0.01%	6770
2017 Q4	–	Sell	-10,000	Closed	-$267K	–	7947
2017 Q3	$267K	Buy	+10,000	New	+$246K	﹤0.01%	6245

Other funds holding BAK

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

LCM

Lonestar Capital Management San Francisco, California $671M AUM 72.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's BAK Position: Q1 2026 in Review

Citadel Advisors sold out of Braskem (BAK) in Q1 2026, closing a stake of 59,781 shares — an estimated $176K sold.

Citadel Advisors first reported a position in BAK in Q2 2014 and held it in 27 quarters. The position peaked at $6.98M in Q2 2017. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.

Citadel Advisors reported no remaining Braskem position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 59,781 Braskem shares in Q1 2026, an estimated $176K.
Citadel Advisors first reported a position in Braskem in Q2 2014 and held it in 27 quarters.
Citadel Advisors's Braskem position peaked at $6.98M in Q2 2017.
64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.